QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Business Wire
New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settingsFindings show QuantiFERON testing is cost-effective compared with tuberculin skin testing in people living with HIVCPD-accredited online QuantiFERON World TB Day program on March 24 convenes global experts to advance TB detection, prevention and high-impact scientific exchange GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus (QFT-Plus) blood test for detecting tuberculosis (TB) infection, particularly in immunocompromised and other high-risk populations.The announcement is being made in time for World TB Day to underscore the continued importance of improving TB detection and prevention globally. The global QuantiFERON World TB Day event will take place online on March 24, 2026, with two
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Qiagen Announces Form 20-F Annual Report Filing for 2025 Results [Yahoo! Finance]Yahoo! Finance
- Qiagen Announces Form 20-F Annual Report Filing for 2025 ResultsBusiness Wire
- QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention [Yahoo! Finance]Yahoo! Finance
- Qiagen (QGEN) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 2/4/26 - Beat
QGEN
Sec Filings
- 3/20/26 - Form 20-F
- 3/20/26 - Form IRANNOTICE
- 2/10/26 - Form SCHEDULE
- QGEN's page on the SEC website